Reaction
Humoral Immune Defect reporting signals
As of the last recalculation, Humoral Immune Defect appears in 367 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is BENDAMUSTINE HCL (PRR 221.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bendamustine Hcl | 52 | 221.4 | 222.2 |
| Rituximab | 207 | 126.1 | 126.2 |
| Remdesivir | 16 | 71.1 | 71.2 |
| Bendamustine Hydrochloride | 13 | 63.8 | 63.9 |
| Polatuzumab Vedotin | 6 | 35.4 | 35.5 |
| Obinutuzumab | 10 | 35.4 | 35.4 |
| Doxorubicin | 47 | 34.2 | 34.2 |